Last 48 quarters of trend data · Consumer Defensive · Household & Personal Products
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
The Clorox Company's quarterly P/E stands at 19.5x, down 25.9% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 35.9% YoY to 12.9x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 19.50 | 19.54 | 47.42 | 11.20 | 24.54 | 26.37 | 51.55 | 19.72 | — | 47.53 | 182.03 | 28.00 | — |
| — | -25.9% | -8.0% | -43.2% | — | -44.5% | -71.7% | -29.6% | — | +8.4% | +291.3% | -34.9% | — | |
| P/S Ratio | 2.34 | 1.84 | 2.65 | 1.87 | 2.74 | 3.00 | 2.88 | 2.24 | 2.62 | 2.23 | 2.95 | 2.45 | 2.55 |
| — | -38.8% | -7.9% | -16.7% | +4.4% | +34.5% | -2.2% | -8.7% | +2.6% | -12.0% | +28.9% | +1.3% | +7.3% | |
| P/B Ratio | 32.79 | 351.22 | 109.91 | 30.83 | 96.15 | 167.33 | 90.67 | 34.69 | 74.60 | 81.51 | 124.71 | 51.09 | 113.76 |
| — | +109.9% | +21.2% | -11.1% | +28.9% | +105.3% | -27.3% | -32.1% | -34.4% | +130.0% | +288.8% | +113.4% | +280.5% | |
| P/FCF | 21.85 | 11.42 | 66.53 | 16.96 | 19.60 | 39.86 | 27.90 | 16.47 | 37.45 | 43.98 | — | 14.32 | 17.16 |
| — | -71.3% | +138.4% | +3.0% | -47.7% | -9.4% | — | +15.0% | +118.2% | +68.9% | — | -16.0% | -33.8% | |
| EV / EBITDA | 13.83 | 12.91 | 25.25 | 9.17 | 17.91 | 20.15 | 16.42 | 13.04 | 19.77 | 13.55 | 38.04 | 16.08 | 17.79 |
| — | -35.9% | +53.8% | -29.7% | -9.4% | +48.7% | -56.8% | -18.9% | +11.1% | -44.5% | +80.1% | -27.4% | +0.7% | |
| EV / EBIT | 16.40 | 15.72 | 33.99 | 10.10 | 18.67 | 21.99 | 28.50 | 16.53 | — | 31.13 | 89.72 | 21.44 | — |
| — | -28.5% | +19.2% | -38.9% | — | -29.3% | -68.2% | -22.9% | — | -4.4% | +168.6% | -32.7% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
The Clorox Company's operating margin was 14.4% in Q2 2026, up 5.8 pp QoQ and up 0.6 pp YoY.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.0% | 43.2% | 41.6% | 46.3% | 44.3% | 43.6% | 45.9% | 46.2% | 42.0% | 43.2% | 38.5% | 42.8% | 41.8% |
| — | -1.0% | -9.4% | +0.3% | +5.6% | +1.0% | +19.0% | +7.9% | +0.4% | +20.0% | +8.1% | +17.1% | +17.0% | |
| Operating Margin | 16.6% | 14.4% | 8.6% | 21.2% | 14.3% | 13.8% | 16.7% | 16.8% | 12.0% | 16.2% | 4.6% | 14.2% | 13.3% |
| — | +4.2% | -48.6% | +26.2% | +18.7% | -14.6% | +262.6% | +18.7% | -9.4% | +85.0% | -51.9% | +47.5% | +4.8% | |
| Net Margin | 11.4% | 9.4% | 5.6% | 16.7% | 11.2% | 11.4% | 5.6% | 11.4% | -2.8% | 4.7% | 1.6% | 8.7% | -11.0% |
| — | -18.0% | -0.4% | +47.1% | +496.6% | +144.9% | +254.0% | +30.2% | +74.5% | -19.0% | -67.5% | +55.4% | -232.9% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 166.3% | 181.5% | 25.8% | 98.8% | 119.6% | 111.9% | 27.7% | 57.8% | -21.6% | 53.3% | 8.5% | 62.9% | -63.7% |
| — | +62.2% | -6.7% | +70.9% | +654.7% | +109.9% | +226.2% | -8.0% | +66.1% | +165.7% | -38.9% | +306.1% | -326.4% | |
| ROA | 14.3% | 2.8% | 1.4% | 6.0% | 3.4% | 3.5% | 1.8% | 3.7% | -0.9% | 1.6% | 0.4% | 3.0% | -3.6% |
| — | -19.1% | -18.0% | +60.4% | +485.2% | +123.0% | +377.6% | +24.9% | +75.5% | -3.7% | -73.3% | +84.9% | -248.4% | |
| ROIC | 27.7% | 6.0% | 3.0% | 10.4% | 6.1% | 6.1% | 7.3% | 7.7% | 5.4% | 8.3% | 1.7% | 7.3% | 6.0% |
| — | -2.0% | -59.8% | +35.0% | +13.2% | -26.9% | +340.9% | +5.6% | -9.7% | +152.6% | -52.9% | +102.5% | +23.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The Clorox Company's Debt/EBITDA ratio is 10.9x, down from 17.2x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 22.0% YoY to 0.74x, tightening the short-term liquidity position. Debt/Equity has risen for 3 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 5.98 | 91.91 | 22.30 | 5.98 | 15.49 | 25.55 | 12.88 | 5.90 | 11.84 | 14.35 | 24.45 | 7.54 | 17.59 |
| — | +259.7% | +73.2% | +1.3% | +30.8% | +78.0% | -47.3% | -21.7% | -32.7% | +128.6% | +277.9% | +77.0% | +212.4% | |
| Debt / EBITDA | 2.06 | 10.87 | 17.20 | 6.01 | 10.05 | 10.81 | 8.26 | 7.66 | 10.94 | 8.26 | 25.62 | 8.40 | 9.63 |
| — | +0.5% | +108.1% | -21.5% | -8.2% | +31.0% | -67.8% | -8.8% | +13.6% | -44.3% | +78.1% | -37.7% | -15.0% | |
| Current Ratio | 0.84 | 0.74 | 0.76 | 0.84 | 0.74 | 0.94 | 1.00 | 1.03 | 0.90 | 0.89 | 0.86 | 0.95 | 0.87 |
| — | -22.0% | -24.0% | -18.7% | -18.0% | +5.7% | +16.4% | +8.1% | +2.9% | +3.3% | -2.2% | -1.4% | +23.6% | |
| Quick Ratio | 0.57 | 0.48 | 0.50 | 0.57 | 0.44 | 0.60 | 0.62 | 0.63 | 0.53 | 0.57 | 0.54 | 0.59 | 0.51 |
| — | -20.6% | -19.5% | -9.7% | -17.1% | +5.8% | +15.4% | +6.0% | +5.7% | +21.1% | +7.5% | +8.6% | +25.5% | |
| Interest Coverage | 11.67 | 8.61 | 4.73 | 16.88 | 8.81 | 9.32 | 12.29 | 13.33 | 8.38 | 11.10 | 2.67 | 11.92 | 9.07 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonThe Clorox Company's current P/E is 19.5x. The average P/E over the last 4 quarters is 25.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
The Clorox Company's current operating margin is 16.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking The Clorox Company's business trajectory between earnings reports.